ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.879,43
-1,20%
S&P 500
5.297,47
-0,45%
US Dollar vs BRL
5,1542
0,60%
Bitcoin
69.527,56
-0,86%
Brent Oil
81,50
-1,15%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. iBio Inc (IBIO)

  7. iBio Inc (IBIO) Notícias

IBIO

iBio (IBIO)

iBio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:IBIO
DataHoraFonteTítuloCódigoCompanhia
20/05/202407:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
13/05/202417:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202417:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
13/05/202417:05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202408:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
26/03/202420:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202409:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
16/01/202410:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
10/01/202415:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
04/01/202410:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202309:15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
06/12/202310:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
05/12/202310:00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
05/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
30/11/202310:55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
27/11/202319:20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
01/11/202309:24GlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
27/10/202317:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
26/10/202309:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
26/10/202309:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:IBIOiBio Inc
16/10/202317:59Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:IBIOiBio Inc
10/10/202309:00GlobeNewswire Inc.iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of BiologicsAMEX:IBIOiBio Inc
02/10/202307:45GlobeNewswire Inc.iBio Explains Recent Filing of Registration StatementAMEX:IBIOiBio Inc
29/09/202318:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:IBIOiBio Inc
27/09/202317:19GlobeNewswire Inc.iBio Announces Filing of 2023 Annual Report on SEC Form 10-KAMEX:IBIOiBio Inc
27/09/202317:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:IBIOiBio Inc
21/09/202317:05GlobeNewswire Inc.iBio Announces Amendment to Credit Agreement with WoodforestAMEX:IBIOiBio Inc
15/08/202317:02Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:IBIOiBio Inc
14/08/202317:15GlobeNewswire Inc.iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical DevelopmentAMEX:IBIOiBio Inc
07/08/202310:29Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:IBIOiBio Inc
 Apresentando as notícias mais relevantes sobre:AMEX:IBIO

Seu Histórico Recente

COIN
LCXUST
LCX
LSE
72OA
Lloyds Bk.stp09
FX
SEKZAR
SEK vs ZAR
TSX
HEJ
Horizons Enhanced Income...
LSE
0UNS
Ibu Tec Advanced Materials
COIN
SELUSD
LSE
79AG
Arab Rep.egp 32
EU
SES5G
Euronext Sovereign Econo...
NASDAQ
IUSB
Total USD Bond Market ETF
LSE
HVPD
Harbourvest Global Priva...
DBI
I1HU
STOXX DAX TTM
USOTC
DYLLF
Deep Yellow (QX)
LATK
RAIBTC
Rai Reflex Index
BOV
F1LS34
Flowserve
LSE
IX.
I(x) Net Zero
COIN
OOEETH
OpenOcean
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados